BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial ...Middle East

BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been included in a clinical trial sponsored by...

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial )

Also on site :

• Country Superstar Jelly Roll Dishes on His ‘Awesome’ Experience Running a 5K: ‘ I Was Proud of Myself'
• Mexican Mother's Day 2025: Everything To Know
• Tim McGraw Fans Laud 'Beautiful Moment' in Country Star's Bold Career Announcement